A Phase 2, Double-blind, Randomized, Placebo-controlled Milticenter Study to Evaluate Efficacy, Safety, and Tolerability of JBT-101 in Systemic Lupus Erythematosus

Administered By

Medicine, Rheumatology and Immunology

Awarded By

University of California - San Francisco

Contributors

Clowse, Megan Elizabeth Bowles Principal Investigator

Start/End

January 1, 2017 - October 31, 2019